Literature DB >> 18329944

Apoptosis signalling is essential and precedes protein degradation in wasting skeletal muscle during catabolic conditions.

Josep M Argilés1, Francisco J López-Soriano, Sílvia Busquets.   

Abstract

Activation of skeletal muscle proteolysis leads to wasting in many types of catabolic/chronic diseases. Protein breakdown is basically accomplished by the activation of the ubiquitin-proteasome system. Interestingly, several publications have shown that DNA fragmentation also occurs in skeletal muscle tissue during catabolism. The present review suggests that activation of apoptosis precedes protein breakdown associated with muscle wasting. In addition, the role of the different proteolytic systems and their relation with apoptosis is emphasized. Altogether, the data presented could be used for the design of new approaches for the treatment of muscle wasting diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329944     DOI: 10.1016/j.biocel.2008.02.001

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  20 in total

Review 1.  Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.

Authors:  Thomas W Buford; Stephen D Anton; Andrew R Judge; Emanuele Marzetti; Stephanie E Wohlgemuth; Christy S Carter; Christiaan Leeuwenburgh; Marco Pahor; Todd M Manini
Journal:  Ageing Res Rev       Date:  2010-05-14       Impact factor: 10.895

Review 2.  Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty - a mini-review.

Authors:  Emanuele Marzetti; Riccardo Calvani; Roberto Bernabei; Christiaan Leeuwenburgh
Journal:  Gerontology       Date:  2011-09-23       Impact factor: 5.140

3.  Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7.

Authors:  Wei A He; Federica Calore; Priya Londhe; Alessandro Canella; Denis C Guttridge; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

4.  Ginsenoside Rg1 prevents starvation-induced muscle protein degradation via regulation of AKT/mTOR/FoxO signaling in C2C12 myotubes.

Authors:  Fengyu Li; Xiaoxue Li; Xuewei Peng; Lili Sun; Shengnan Jia; Ping Wang; Shuang Ma; Hongyan Zhao; Qingmiao Yu; Hongliang Huo
Journal:  Exp Ther Med       Date:  2017-06-15       Impact factor: 2.447

5.  Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice.

Authors:  Kristen A Baltgalvis; Franklin G Berger; Maria Marjorette O Peña; J Mark Davis; James P White; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2010-07-22

6.  Combined treatment of carfilzomib and z-VAD-fmk inhibits skeletal proteolysis and apoptosis and ameliorates cancer cachexia.

Authors:  Qiang Wang; Chunhong Li; Xudong Peng; Qingjie Kang; Dawei Deng; Liuping Zhang; Yueyong Zheng; Chaoyi Wang; Zhongpeng Qiao; Dunwei Guo; Song You; Hua Tang
Journal:  Med Oncol       Date:  2015-03-04       Impact factor: 3.064

7.  Muscle-specific RING finger (MuRF) cDNAs in Atlantic salmon (Salmo salar) and their role as regulators of muscle protein degradation.

Authors:  Luca Tacchi; Ralph Bickerdike; Christopher J Secombes; Samuel A M Martin
Journal:  Mar Biotechnol (NY)       Date:  2011-05-17       Impact factor: 3.619

8.  Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's disease.

Authors:  Pengxiang She; Zhiyou Zhang; Deanna Marchionini; William C Diaz; Thomas J Jetton; Scot R Kimball; Thomas C Vary; Charles H Lang; Christopher J Lynch
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-04-19       Impact factor: 4.310

9.  Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction.

Authors:  Emanuele Marzetti; Christy S Carter; Stephanie E Wohlgemuth; Hazel A Lees; Silvia Giovannini; Barbara Anderson; LeBris S Quinn; Christiaan Leeuwenburgh
Journal:  Mech Ageing Dev       Date:  2009-04       Impact factor: 5.432

Review 10.  Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2013-03-19       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.